Carvipress Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Carvedilol

Indications/Uses

Management of essential HTN.

Click to view Carvipress detailed prescribing information

Dosage/Direction for Use

HTN Initially 6.25 mg once daily for 1st 2 days, then 12.5 mg once daily thereafter. Max daily dose: 50 mg.

Click to view Carvipress detailed prescribing information

Overdosage

View Carvipress overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. 2nd- or 3rd-degree heart block, severe bradycardia, shock, uncontrolled heart failure, asthma, history of chronic obstructive airways disease, hepatic impairment.

Click to view Carvipress detailed prescribing information

Special Precautions

Poor cardiac reserve. Control heart failure prior to therapy. Avoid abrupt w/drawal in patients w/ ischaemic heart disease. May mask symptoms of hyperthyroidism & early signs of acute hypoglycemia in patients w/ DM. May impair ability to drive or operate machinery. Pregnancy & lactation.

Click to view Carvipress detailed prescribing information

Use In Pregnancy & Lactation

Click to view Carvipress detailed prescribing information

Adverse Reactions

Symptomatic postural hypotension, dizziness, headache, fatigue, GI upset, bradycardia; diminished peripheral circulation, dry eyes, flu-like symptoms.

Click to view Carvipress detailed prescribing information

Drug Interactions

General anesth, other β-blockers, class I antiarrhythmic drugs or Ca antagonists eg verapamil.

Click to view Carvipress detailed prescribing information

Storage

View Carvipress storage conditions for details to ensure optimal shelf-life.

Action

View Carvipress mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Beta-Blockers

ATC Classification

C07AG02 - carvedilol ; Belongs to the class of alpha and beta blocking agents. Used in the treatment of cardiovascular diseases.

Regulatory Classification

POM

Presentation/Packing

Form

Carvipress tab 3.125 mg

Packing/Price

3 × 10's

Carvipress

carvedilol

Manufacturer:

Micro Labs

Distributor:

Zizawa Healthcare